Used primarily in the development of pharmaceutical agents targeting the central nervous system. Its structure supports binding to neurotransmitter receptors, making it a key intermediate in synthesizing antipsychotic and anticholinergic drugs. Commonly employed in research for treating neurological disorders such as schizophrenia and Parkinson’s disease. Also explored for its potential in managing nausea and vomiting due to its interaction with dopamine receptors. Widely utilized in medicinal chemistry for structure-activity relationship studies to optimize receptor selectivity and reduce side effects in new drug candidates.